Cryo-shocked cancer cell microgels for tumor postoperative combination immunotherapy and tissue regeneration

• Published in: Bioactive materials Vol. 28; pp. 326 - 336
• Main Authors: Kuang, Gaizhen, Zhang, Qingfei, Yu, Yunru, Shang, Luoran, Zhao, Yuanjin
• Format: Journal Article
• Language: English
• Published: China Elsevier B.V 01.10.2023; KeAi Publishing; KeAi Communications Co., Ltd
• Subjects: Immunotherapy; Microfluidics; Microgel; Regeneration; Vaccine; Regeneration; Microgel; Vaccine; Immunotherapy; Microfluidics
• ISSN: 2452-199X; 2452-199X
• DOI: 10.1016/j.bioactmat.2023.05.021

Prevention of recurrence/metastasis and tissue regeneration are critical for post-surgery treatment of malignant tumors. Here, to address these needs, a novel type of microgel co-loading cryo-shocked cancer cells, immunoadjuvant, and immune checkpoint inhibitor is presented by microfluidic electrospray technology and liquid nitrogen treatment. Owing to the encapsulation of cryo-shocked cancer cells and immunoadjuvant, the microgels can recruit dendritic cells and activate them in situ, and evoke a robust immune response. Moreover, with the combination of the immune checkpoint inhibitor, the antitumor immune response is further enhanced by inhibiting the interaction of PD1 and PDL1. With this, the excellent anti-recurrence and anti-metastasis efficacy of the microgels are demonstrated in an orthotopic breast cancer mouse model. Besides, because of the excellent biocompatibility and appropriate degradation performance, the microgels can provide support for normal cell adhesion and growth, which is beneficial to tissue reconstruction. These properties indicate the great value of the cryo-shocked cancer cell microgels for efficient tumor postoperative combination immunotherapy and tissue regeneration. [Display omitted] •Novel microgels were prepared by microfluidic with liquid nitrogen collection.•A robust immune response was provoked by the microgel-based cancer vaccine.•Synergized enhanced combination immunotherapy was displayed in vivo.•The system for postoperative oncotherapy and tissue regeneration is potential.